February 2016

ERDF funds enable the incorporation of CMRB to IDIBELL’s facilities

Leave a Comment / Uncategorised / By

The Spanish Ministry of Economy and Competitiveness (MINECO) has granted a project to Bellvitge Biomedical Research Institute (IDIBELL) for the optimization, adaptation, improvement of facilities and acquisition of technological equipment at IDIBELL because of the forthcoming integration of the Center for Regenerative Medicine in Barcelona (CMRB) in these spaces. The project, which is funded by […]

ERDF funds enable the incorporation of CMRB to IDIBELL’s facilities Read More »

ICFO and IDIBELL, together into new projects

Leave a Comment / Tumour Angiogenesis / By

joint conference ICFO-IDIBELL Detecting , Predicting and Fighting Resistance to antiangiogenic Therapies Non-invasive Monitoring of Local Hemodynamics to Characterize Suspicious Masses and to Predict Therapy Outcomes Applications to Biomedicine of Light and Nanotechnology Superresolution Techniques to Study Polarized Trafficking of Signaling Proteins in Photoreceptor Cells of the Retina Advanced Microscopy Techniques: Biomedical Imaging Applications at Nano, Micro and Macro Levels.

ICFO and IDIBELL, together into new projects Read More »

Identify a biochemical alteration responsible for the resistance of the most aggressive brain tumors

Leave a Comment / Uncategorised / By

Researchers at the Institute of Neurosciences, UAB (INC) have identified the biochemical and molecular alterations leading to resistance to radiotherapy and chemotherapy in glioblastoma, the most aggressive brain tumor. The finding could allow, in the future, to design new, more effective therapies. Original article:

Identify a biochemical alteration responsible for the resistance of the most aggressive brain tumors Read More »

Xavier Bosch, IDIBELL Ombudsman

Leave a Comment / Uncategorised / By

On October 14th, 2015, Dr. Francesc Xavier Bosch was presented and sanctioned by the Internal IDIBELL Scientific Committee as the Ombudsman of the institution. Dr. Bosch, Doctor of Medicine from the Autonomous University of Barcelona, has been responsible for the Cancer Epidemiology Research Program of the Catalan Institute of Oncology (ICO), head of the Infection

Xavier Bosch, IDIBELL Ombudsman Read More »

A new therapeutic strategy for more aggressive lung tumor

Tumor and stromal chemoresistance  / By

Lung cancer is one of the most prevalent, with more than 20,000 new cases diagnosed each year in Spain. In 30% intervenes KRAS oncogene, which causes more aggressive tumor. It is also a type of lung cancer that does not has targeted therapies beyond the standard cisplatin. A study led by researchers Mariano Barbacid and

A new therapeutic strategy for more aggressive lung tumor Read More »

Eva Gonzalez Suarez gets Consolidator Grant from the European Research Council

Leave a Comment / Transformation and Metastasis / By

The head of the group of Transformation and Metastasis PEBC-IDIBELL, Eva Gonzalez Suarez has received an ERC Consolidator Grant from the European Research Council (ERC) to develop its PLEIO-RANK project to develop a single therapy capable of reducing metastasis and mortality in solid tumors. The grant supposes a funding 2 million Euros for the next five years.

Eva Gonzalez Suarez gets Consolidator Grant from the European Research Council Read More »

Researcher Oriol Casanovas received a Proof of Concept 2015 grant awarded by the European Union

Leave a Comment / Tumour Angiogenesis / By

The European Research Council (ERC) has announced the names of the scientists who will receive the Proof of Concept (PoC) 2015 grant, which is only accessible to scientists who already have a grant from the ERC. Oriol Casanovas, leader of the Tumor Angiogenesis group of the PROCURE program from ICO and IDIBELL has been one

Researcher Oriol Casanovas received a Proof of Concept 2015 grant awarded by the European Union Read More »

UB invest doctor honoris causa the oncologist and epidemiologist Francesc Xavier Bosch

Leave a Comment / Uncategorised / By

The oncologist and epidemiologist Francesc Xavier Bosch has been awarded an honorary doctorate (Honoris Causa) by the University of Barcelona today February 11th, 2016. At the ceremony, which was held in the Paranimf, have acted as guarantors Francesc Cardellach, dean of the Faculty of Medicine, UB, and Victor Raul Moreno, professor of the Department of

UB invest doctor honoris causa the oncologist and epidemiologist Francesc Xavier Bosch Read More »

Scroll to Top